Phase 2/3 trials of COVID-19 vaccine ‘Covovax’ in children from age 7 to 11 has begun in Pune’s Bharati Vidyapeeth Medical College and Hospital on 29th September.
Covovax is the Indian version of the Novovax vaccine for children, which has been introduced in India by the Serum Institute of India. The Covid vaccine trial for the paediatric age group began at 9 centres in India, with volunteers ranging in age from 2 to 17 years old.
Dr. Sanjay Lalwani, the Medical Director of the hospital told that nine children have been enrolled for the trial in the hospital, adding he said “For the children who wish to enrol their parents are counselled in local vernacular language and the audiovisual consulting process is documented. Once the parents give their consent, then the volunteer is subjected to an RT PCR test and an antibody test. Although, this does not stop them from being a part of the trial.”
Two doses at a gap of 21 days will be administered during the trial.
“In paediatric, it’s an age de-escalation trial; which means that you start with children of higher age and see the efficacy, and then proceed to the lower ages. So, part one is between the 11-17 age group where 100s have been enrolled in India. There are 9 sites in India and approx 1,000 children will enrol across the county. We at our site have started the trial for the age group of 7-11,” Dr. Lalwani said.
Click here for Latest News updates and viral videos on our AI-powered smart news
For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram